Notice: Global Information Announces Listing on JASDAQ Standard Market of the Tokyo Stock Exchange

Cover Image
Market Research Report

Middle East and Africa Syndromic Multiplex Diagnostic Market - Industry Trends and Forecast to 2027

Published by Data Bridge Market Research Private Limited Product code 953499
Published Content info 80 Pages
Delivery time: 1-2 business days
Price
Back to Top
Middle East and Africa Syndromic Multiplex Diagnostic Market - Industry Trends and Forecast to 2027
Published: July 1, 2020 Content info: 80 Pages
Description

Middle East and Africa syndromic multiplex diagnostic market is projected to register a substantial CAGR in the forecast period of 2020 to 2027. The new market report contains data for historic year 2018, the base year of calculation is 2019 and the forecast period is 2020 to 2027.

Market Segmentation

Middle East and Africa Syndromic Multiplex Diagnostic Market, By Products and Services (Reagents & Consumables, Instruments & Accessories and Software & Services), Infection Type (Viral, Bacterial, Parasites, Fungal and Others), Disease (Respiratory Infections, Gastroenteritis, Sexually Transmitted Infections, Hepatitis, Tropical Fever, Meningitis, Childhood Infections, Immunosuppression and Eye Infections), Panels Type (Respiratory Panel, GI-Enteric Panel, Sexually Transmitted Disease Panel, Blood-Sepsis Panel, Meningitis Panel and Others), End User (Hospitals, Clinical Laboratories, Pharmaceutical & Biotechnology Companies, Research Institutes, Physician Office Lab's and Others), Country (South Africa and Rest of Middle East and Africa) Industry Trends and Forecast to 2027

Some of the major factors contributing to the growth of the Middle East and Africa syndromic multiplex diagnostic market are:

Increasing demand for accurate and fast diagnostic results.

Improving diagnosis seeking rate.

Market Players:

The key market players for Middle East and Africa syndromic multiplex diagnostic market are listed below:

GenMark Diagnostics, Inc.

QuantuMDx Group Ltd.

BioFire Diagnostics (a subsidiary of bioMerieux SA)

Bio-Rad Laboratories, Inc.

Thermo Fisher Scientific Inc.

Siemens Healthcare GmbH

QIAGEN

Hologic, Inc.

F. Hoffmann-La Roche Ltd

BD

Danaher

Curetis

Abbott

DiaSorin S.p.A.

Bosch Healthcare Solutions GmbH (a subsidiary of Robert Bosch GmbH)

Biocartis

Luminex Corporation

Seegene Inc.

Table of Contents

TABLE OF CONTENTS

1 INTRODUCTION

  • 1.1 OBJECTIVES OF THE STUDY
  • 1.2 MARKET DEFINITION
  • 1.3 OVERVIEW OF MIDDLE EAST & AFRICA SYNDROMIC MULTIPLEX DIAGNOSTIC MARKET
  • 1.4 LIMITATIONS
  • 1.5 MARKETS COVERED

2 MARKET SEGMENTATION

  • 2.1 MARKETS COVERED
  • 2.2 GEOGRAPHICAL SCOPE
  • 2.3 YEARS CONSIDERED FOR THE STUDY
  • 2.4 CURRENCY AND PRICING
  • 2.5 DBMR TRIPOD DATA VALIDATION MODEL
  • 2.6 MULTIVARIATE MODELLING
  • 2.7 PRODUCTS AND SERVICES LIFELINE CURVE
  • 2.8 PRIMARY INTERVIEWS WITH KEY OPINION LEADERS
  • 2.9 DBMR MARKET POSITION GRID
  • 2.10 VENDOR SHARE ANALYSIS
  • 2.11 SECONDARY SOURCES
  • 2.12 ASSUMPTIONS

3 EXECUTIVE SUMMARY

4 PREMIUM INSIGHTS

5 MARKET OVERVIEW

  • 5.1 DRIVERS
    • 5.1.1 GROWING PREVALENCE OF INFECTION DISEASES
    • 5.1.2 GROWING ADOPTION OF MOLECULAR DIAGNOSTICS
    • 5.1.3 INCREASING REGULATORY APPROVAL FOR SEVERE ACUTE RESPIRATORY SYNDROME CORONAVIRUS 2 (SARS-COV-2) TESTING
    • 5.1.4 INCREASING DEMAND FOR ACCURATE AND FAST DIAGNOSTIC RESULTS
    • 5.1.5 IMPROVING DIAGNOSIS SEEKING RATE
  • 5.2 RESTRAINTS
    • 5.2.1 HIGH COST OF DIAGNOSTIC PRODUCTS
    • 5.2.2 EXPLICIT LIMITATION OF SYNDROMIC MULTIPLEX DIAGNOSTIC
  • 5.3 OPPORTUNITIES
    • 5.3.1 INCREASING DIAGNOSTIC HEALTHCARE EXPENDITURE
    • 5.3.2 INTRODUCTION OF TECHNOLOGICALLY ADVANCED PRODUCTS
  • 5.4 CHALLENGES
    • 5.4.1 STRICT REGULATIONS AND STANDARDS FOR THE APPROVAL AND COMMERCIALIZATION OF DIAGNOSTIC PRODUCTS
    • 5.4.2 LACK OF SKILLED PROFESSIONALS AND BARRIERS FACED IN CONDUCTING DIAGNOSTIC TESTS

6 IMPACT OF COVID-19 ON MIDDLE EAST & AFRICA SYNDROMIC MULTIPLEX DIAGNOSTIC MARKET

  • 6.1 IMPACT ANALYSIS ON DEMAND
  • 6.2 CONCLUSION

7 MIDDLE EAST & AFRICA SYNDROMIC MULTIPLEX DIAGNOSTIC MARKET, BY PRODUCTS AND SERVICES

  • 7.1 OVERVIEW
  • 7.2 REAGENTS & CONSUMABLES
  • 7.3 INSTRUMENTS & ACCESSORIES
  • 7.4 SOFTWARE & SERVICES

8 MIDDLE EAST & AFRICA SYNDROMIC MULTIPLEX DIAGNOSTIC MARKET, BY INFECTION TYPE

  • 8.1 OVERVIEW
  • 8.2 VIRAL
    • 8.2.1 RHINOVIRUS
    • 8.2.2 ROTAVIRUS
    • 8.2.3 ADENOVIRUS
    • 8.2.4 CORONAVIRUS
    • 8.2.5 OTHERS
  • 8.3 BACTERIAL
    • 8.3.1 PNEUMONIAE
    • 8.3.2 BORDETELLA PERTUSSIS
    • 8.3.3 STAPHYLOCOCCUS
    • 8.3.4 OF OTHERS
  • 8.4 PARASITES
  • 8.5 FUNGAL
  • 8.6 OTHERS

9 MIDDLE EAST & AFRICA SYNDROMIC MULTIPLEX DIAGNOSTIC MARKET, BY DISEASE

  • 9.1 OVERVIEW
  • 9.2 RESPIRATORY INFECTIONS
  • 9.3 GASTROENTERITIS
  • 9.4 SEXUALLY TRANSMITTED INFECTIONS
  • 9.5 HEPATITIS
  • 9.6 TROPICAL FEVER
  • 9.7 MENINGITIS
  • 9.8 CHILDHOOD INFECTIONS
  • 9.9 IMMUNOSUPPRESSION
  • 9.10 EYE INFECTIONS

10 MIDDLE EAST & AFRICA SYNDROMIC MULTIPLEX DIAGNOSTIC MARKET, BY PANELS TYPE

  • 10.1 OVERVIEW
  • 10.2 RESPIRATORY PANEL
  • 10.3 GI-ENTERIC PANEL
  • 10.4 SEXUALLY TRANSMITTED DISEASE PANEL
  • 10.5 BLOOD-SEPSIS PANEL
  • 10.6 MENINGITIS PANEL
  • 10.7 OTHERS

11 MIDDLE EAST & AFRICA SYNDROMIC MULTIPLEX DIAGNOSTIC MARKET, BY END USER

  • 11.1 OVERVIEW
  • 11.2 HOSPITALS
  • 11.3 CLINICAL LABORATORIES
  • 11.4 PHARMACEUTICAL & BIOTECHNOLOGY COMPANIES
  • 11.5 RESEARCH INSTITUTES
  • 11.6 PHYSICIAN OFFICE LAB'S
  • 11.7 OTHERS

12 MIDDLE EAST & AFRICA SYNDROMIC MULTIPLEX DIAGNOSTIC MARKET, BY GEOGRAPHY

  • 12.1 MIDDLE EAST AND AFRICA
    • 12.1.1 SOUTH AFRICA
    • 12.1.2 REST OF MIDDLE EAST AND AFRICA

13 MIDDLE EAST & AFRICA SYNDROMIC MULTIPLEX DIAGNOSTIC MARKET, COMPANY LANDSCAPE

  • 13.1 COMPANY SHARE ANALYSIS: MIDDLE EAST & AFRICA

14 SWOT ANALYSIS

15 COMPANY PROFILE

  • 15.1 BIOFIRE DIAGNOSTICS (A SUBSIDIARY OF BIOMERIEUX SA)
    • 15.1.1 COMPANY SNAPSHOT
    • 15.1.2 REVENUE ANALYSIS
    • 15.1.3 COMPANY SHARE ANALYSIS
    • 15.1.4 PRODUCT PORTFOLIO
    • 15.1.5 RECENT DEVELOPMENTS
  • 15.2 SIEMENS HEALTHCARE GMBH
    • 15.2.1 COMPANY SNAPSHOT
    • 15.2.2 REVENUE ANALYSIS
    • 15.2.3 COMPANY SHARE ANALYSIS
    • 15.2.4 PRODUCT PORTFOLIO
    • 15.2.5 RECENT DEVELOPMENTS
  • 15.3 F. HOFFMANN-LA ROCHE LTD
    • 15.3.1 COMPANY SNAPSHOT
    • 15.3.2 REVENUE ANALYSIS
    • 15.3.3 COMPANY SHARE ANALYSIS
    • 15.3.4 PRODUCT PORTFOLIO
    • 15.3.5 RECENT DEVELOPMENT
  • 15.4 THERMO FISHER SCIENTIFIC INC.
    • 15.4.1 COMPANY SNAPSHOT
    • 15.4.2 REVENUE ANALYSIS
    • 15.4.3 COMPANY SHARE ANALYSIS
    • 15.4.4 PRODUCT PORTFOLIO
    • 15.4.5 RECENT DEVELOPMENT
  • 15.5 BD
    • 15.5.1 COMPANY SNAPSHOT
    • 15.5.2 REVENUE ANALYSIS
    • 15.5.3 COMPANY SHARE ANALYSIS
    • 15.5.4 PRODUCT PORTFOLIO
    • 15.5.5 RECENT DEVELOPMENTS
  • 15.6 SEEGENE INC.
    • 15.6.1 COMPANY SNAPSHOT
    • 15.6.2 REVENUE ANALYSIS
    • 15.6.3 PRODUCT PORTFOLIO
    • 15.6.4 RECENT DEVELOPMENTS
  • 15.7 ABBOTT
    • 15.7.1 COMPANY SNAPSHOT
    • 15.7.2 REVENUE ANALYSIS
    • 15.7.3 PRODUCT PORTFOLIO
    • 15.7.4 RECENT DEVELOPMENT
  • 15.8 APPLIED BIOCODE, INC.
    • 15.8.1 COMPANY SNAPSHOT
    • 15.8.2 PRODUCT PORTFOLIO
    • 15.8.3 RECENT DEVELOPMENTS
  • 15.9 BIOCARTIS
    • 15.9.1 COMPANY SNAPSHOT
    • 15.9.2 REVENUE ANALYSIS
    • 15.9.3 PRODUCT PORTFOLIO
    • 15.9.4 RECENT DEVELOPMENT
  • 15.10 BIO-RAD LABORATORIES, INC.
    • 15.10.1 COMPANY SNAPSHOT
    • 15.10.2 REVENUE ANALYSIS
    • 15.10.3 PRODUCT PORTFOLIO
    • 15.10.4 RECENT DEVELOPMENT
  • 15.11 BOSCH HEALTHCARE SOLUTIONS GMBH (A SUBSIDIARY OF ROBERT BOSCH GMBH)
    • 15.11.1 COMPANY SNAPSHOT
    • 15.11.2 REVENUE ANALYSIS
    • 15.11.3 PRODUCT PORTFOLIO
    • 15.11.4 RECENT DEVELOPMENT
  • 15.12 CURETIS
    • 15.12.1 COMPANY SNAPSHOT
    • 15.12.2 PRODUCT PORTFOLIO
    • 15.12.3 RECENT DEVELOPMENT
  • 15.13 DANAHER
    • 15.13.1 COMPANY SNAPSHOT
    • 15.13.2 REVENUE ANALYSIS
    • 15.13.3 PRODUCT PORTFOLIO
    • 15.13.4 RECENT DEVELOPMENT
  • 15.14 DIASORIN S.P.A.
    • 15.14.1 COMPANY SNAPSHOT
    • 15.14.2 REVENUE ANALYSIS
    • 15.14.3 PRODUCT PORTFOLIO
    • 15.14.4 RECENT DEVELOPMENTS
  • 15.15 GENMARK DIAGNOSTICS, INC.
    • 15.15.1 COMPANY SNAPSHOT
    • 15.15.2 REVENUE ANALYSIS
    • 15.15.3 PRODUCT PORTFOLIO
    • 15.15.4 RECENT DEVELOPMENTS

  • 15.16 HOLOGIC, INC.
    • 15.16.1 COMPANY SNAPSHOT
    • 15.16.2 REVENUE ANALYSIS
    • 15.16.3 PRODUCT PORTFOLIO
    • 15.16.4 RECENT DEVELOPMENTS
  • 15.17 LUMINEX CORPORATION
    • 15.17.1 COMPANY SNAPSHOT
    • 15.17.2 REVENUE ANALYSIS
    • 15.17.3 PRODUCT PORTFOLIO
    • 15.17.4 RECENT DEVELOPMENT
  • 15.18 NANOMIX, INC.
    • 15.18.1 COMPANY SNAPSHOT
    • 15.18.2 PRODUCT PORTFOLIO
    • 15.18.3 RECENT DEVELOPMENTS
  • 15.19 PROMINEX
    • 15.19.1 COMPANY SNAPSHOT
    • 15.19.2 PRODUCT PORTFOLIO
    • 15.19.3 RECENT DEVELOPMENT
  • 15.20 QIAGEN
    • 15.20.1 COMPANY SNAPSHOT
    • 15.20.2 REVENUE ANALYSIS
    • 15.20.3 PRODUCT PORTFOLIO
    • 15.20.4 RECENT DEVELOPMENT
  • 15.21 QUANTUMDX GROUP LTD.
    • 15.21.1 COMPANY SNAPSHOT
    • 15.21.2 PRODUCT PORTFOLIO
    • 15.21.3 RECENT DEVELOPMENT

16 QUESTIONNAIRE

17 RELATED REPORTS

LIST OF TABLES

  • TABLE 1 COST OF THE PRODUCT
  • TABLE 2 HEALTHCARE EXPENDITURE IN ASIA-PACIFIC
  • TABLE 3 MIDDLE EAST & AFRICA SYNDROMIC MULTIPLEX DIAGNOSTIC MARKET, BY PRODUCTS AND SERVICES, 2018-2027 (USD MILLION)
  • TABLE 4 MIDDLE EAST & AFRICA REAGENTS & CONSUMABLES IN SYNDROMIC MULTIPLEX DIAGNOSTIC MARKET, BY REGION, 2018-2027 (USD MILLION)
  • TABLE 5 MIDDLE EAST & AFRICA INSTRUMENTS & ACCESSORIES IN SYNDROMIC MULTIPLEX DIAGNOSTIC MARKET, BY REGION, 2018-2027 (USD MILLION)
  • TABLE 6 MIDDLE EAST & AFRICA SOFTWARE & SERVICES IN SYNDROMIC MULTIPLEX DIAGNOSTIC MARKET, BY REGION, 2018-2027 (USD MILLION)
  • TABLE 7 MIDDLE EAST & AFRICA SYNDROMIC MULTIPLEX DIAGNOSTIC MARKET, BY INFECTION TYPE, 2018-2027 (USD MILLION)
  • TABLE 8 MIDDLE EAST & AFRICA VIRAL IN SYNDROMIC MULTIPLEX DIAGNOSTIC MARKET, BY REGION, 2018-2027 (USD MILLION)
  • TABLE 9 MIDDLE EAST & AFRICA VIRAL IN SYNDROMIC MULTIPLEX DIAGNOSTIC MARKET, BY INFECTION TYPE, 2018-2027 (USD MILLION)
  • TABLE 10 MIDDLE EAST & AFRICA BACTERIAL IN SYNDROMIC MULTIPLEX DIAGNOSTIC MARKET, BY REGION, 2018-2027 (USD MILLION)
  • TABLE 11 MIDDLE EAST & AFRICA BACTERIAL IN SYNDROMIC MULTIPLEX DIAGNOSTIC MARKET, BY INFECTION TYPE, 2018-2027 (USD MILLION)
  • TABLE 12 MIDDLE EAST & AFRICA PARASITES IN SYNDROMIC MULTIPLEX DIAGNOSTIC MARKET, BY REGION, 2018-2027 (USD MILLION)
  • TABLE 13 MIDDLE EAST & AFRICA FUNGAL IN SYNDROMIC MULTIPLEX DIAGNOSTIC MARKET, BY REGION, 2018-2027 (USD MILLION)
  • TABLE 14 MIDDLE EAST & AFRICA OTHERS IN SYNDROMIC MULTIPLEX DIAGNOSTIC MARKET, BY REGION, 2018-2027 (USD MILLION)
  • TABLE 15 MIDDLE EAST & AFRICA SYNDROMIC MULTIPLEX DIAGNOSTIC MARKET, BY DISEASE, 2018-2027 (USD MILLION)
  • TABLE 16 MIDDLE EAST & AFRICA RESPIRATORY INFECTIONS IN SYNDROMIC MULTIPLEX DIAGNOSTIC MARKET, BY REGION, 2018-2027 (USD MILLION)
  • TABLE 17 MIDDLE EAST & AFRICA GASTROENTERITIS IN SYNDROMIC MULTIPLEX DIAGNOSTIC MARKET, BY REGION, 2018-2027 (USD MILLION)
  • TABLE 18 MIDDLE EAST & AFRICA SEXUALLY TRANSMITTED INFECTIONS IN SYNDROMIC MULTIPLEX DIAGNOSTIC MARKET, BY REGION, 2018-2027 (USD MILLION)
  • TABLE 19 MIDDLE EAST & AFRICA HEPATITIS IN SYNDROMIC MULTIPLEX DIAGNOSTIC MARKET, BY REGION, 2018-2027 (USD MILLION)
  • TABLE 20 MIDDLE EAST & AFRICA TROPICAL FEVER IN SYNDROMIC MULTIPLEX DIAGNOSTIC MARKET, BY REGION, 2018-2027 (USD MILLION)
  • TABLE 21 MIDDLE EAST & AFRICA MENINGITIS IN SYNDROMIC MULTIPLEX DIAGNOSTIC MARKET, BY REGION, 2018-2027 (USD MILLION)
  • TABLE 22 MIDDLE EAST & AFRICA CHILDHOOD INFECTIONS IN SYNDROMIC MULTIPLEX DIAGNOSTIC MARKET, BY REGION, 2018-2027 (USD MILLION)
  • TABLE 23 MIDDLE EAST & AFRICA IMMUNOSUPPRESSION IN SYNDROMIC MULTIPLEX DIAGNOSTIC MARKET, BY REGION, 2018-2027 (USD MILLION)
  • TABLE 24 MIDDLE EAST & AFRICA EYE INFECTIONS IN SYNDROMIC MULTIPLEX DIAGNOSTIC MARKET, BY REGION, 2018-2027 (USD MILLION)
  • TABLE 25 MIDDLE EAST & AFRICA SYNDROMIC MULTIPLEX DIAGNOSTIC MARKET, BY PANELS TYPE, LIFELINE CURVE, 2018-2027 (USD MILLION)
  • TABLE 26 MIDDLE EAST & AFRICA RESPIRATORY PANEL IN SYNDROMIC MULTIPLEX DIAGNOSTIC MARKET, BY REGION, 2018-2027 (USD MILLION)
  • TABLE 27 MIDDLE EAST & AFRICA GI-ENTERIC PANEL IN SYNDROMIC MULTIPLEX DIAGNOSTIC MARKET, BY REGION, 2018-2027 (USD MILLION)
  • TABLE 28 MIDDLE EAST & AFRICA SEXUALLY TRANSMITTED DISEASE PANEL IN SYNDROMIC MULTIPLEX DIAGNOSTIC MARKET, BY REGION, 2018-2027 (USD MILLION)
  • TABLE 29 MIDDLE EAST & AFRICA BLOOD-SEPSIS PANEL IN SYNDROMIC MULTIPLEX DIAGNOSTIC MARKET, BY REGION, 2018-2027 (USD MILLION)
  • TABLE 30 MIDDLE EAST & AFRICA MENINGITIS PANEL IN SYNDROMIC MULTIPLEX DIAGNOSTIC MARKET, BY REGION, 2018-2027 (USD MILLION)
  • TABLE 31 MIDDLE EAST & AFRICA OTHERS IN SYNDROMIC MULTIPLEX DIAGNOSTIC MARKET, BY REGION, 2018-2027 (USD MILLION)
  • TABLE 32 MIDDLE EAST & AFRICA SYNDROMIC MULTIPLEX DIAGNOSTIC MARKET, BY END USER, 2018-2027 (USD MILLION)
  • TABLE 33 MIDDLE EAST & AFRICA HOSPITALS IN SYNDROMIC MULTIPLEX DIAGNOSTIC MARKET, BY REGION, 2018-2027 (USD MILLION)
  • TABLE 34 MIDDLE EAST & AFRICA CLINICAL LABORATORIES IN SYNDROMIC MULTIPLEX DIAGNOSTIC MARKET, BY REGION, 2018-2027 (USD MILLION)
  • TABLE 35 MIDDLE EAST & AFRICA PHARMACEUTICAL & BIOTECHNOLOGY COMPANIES IN SYNDROMIC MULTIPLEX DIAGNOSTIC MARKET, BY REGION, 2018-2027 (USD MILLION)
  • TABLE 36 MIDDLE EAST & AFRICA RESEARCH INSTITUTES IN SYNDROMIC MULTIPLEX DIAGNOSTIC MARKET, BY REGION, 2018-2027 (USD MILLION)
  • TABLE 37 MIDDLE EAST & AFRICA PHYSICIAN OFFICE LAB'S IN SYNDROMIC MULTIPLEX DIAGNOSTIC MARKET, BY REGION, 2018-2027 (USD MILLION)
  • TABLE 38 MIDDLE EAST & AFRICA OTHERS IN SYNDROMIC MULTIPLEX DIAGNOSTIC MARKET, BY REGION, 2018-2027 (USD MILLION)
  • TABLE 39 MIDDLE EAST AND AFRICA SYNDROMIC MULTIPLEX DIAGNOSTIC MARKET, BY COUNTRY, 2018-2027 (USD MILLION)
  • TABLE 40 MIDDLE EAST AND AFRICA SYNDROMIC MULTIPLEX DIAGNOSTIC MARKET, BY PRODUCTS AND SERVICES, 2018-2027 (USD MILLION)
  • TABLE 41 MIDDLE EAST AND AFRICA SYNDROMIC MULTIPLEX DIAGNOSTIC MARKET, BY INFECTION TYPE, 2018-2027 (USD MILLION)
  • TABLE 42 MIDDLE EAST AND AFRICA VIRAL IN SYNDROMIC MULTIPLEX DIAGNOSTIC MARKET, BY INFECTION TYPE, 2018-2027 (USD MILLION)
  • TABLE 43 MIDDLE EAST AND AFRICA BACTERIAL IN SYNDROMIC MULTIPLEX DIAGNOSTIC MARKET, BY INFECTION TYPE, 2018-2027 (USD MILLION)
  • TABLE 44 MIDDLE EAST AND AFRICA SYNDROMIC MULTIPLEX DIAGNOSTIC MARKET, BY DISEASE, 2018-2027 (USD MILLION)
  • TABLE 45 MIDDLE EAST AND AFRICA SYNDROMIC MULTIPLEX DIAGNOSTIC MARKET, BY PANELS TYPE, 2018-2027 (USD MILLION)
  • TABLE 46 MIDDLE EAST AND AFRICA SYNDROMIC MULTIPLEX DIAGNOSTIC MARKET, BY END USER, 2018-2027 (USD MILLION)
  • TABLE 47 SOUTH AFRICA SYNDROMIC MULTIPLEX DIAGNOSTIC MARKET, BY PRODUCTS AND SERVICES, 2018-2027 (USD MILLION)
  • TABLE 48 SOUTH AFRICA SYNDROMIC MULTIPLEX DIAGNOSTIC MARKET, BY INFECTION TYPE, 2018-2027 (USD MILLION)
  • TABLE 49 SOUTH AFRICA VIRAL IN SYNDROMIC MULTIPLEX DIAGNOSTIC MARKET, BY INFECTION TYPE, 2018-2027 (USD MILLION)
  • TABLE 50 SOUTH AFRICA BACTERIAL IN SYNDROMIC MULTIPLEX DIAGNOSTIC MARKET, BY INFECTION TYPE, 2018-2027 (USD MILLION)
  • TABLE 51 SOUTH AFRICA SYNDROMIC MULTIPLEX DIAGNOSTIC MARKET, BY DISEASE, 2018-2027 (USD MILLION)
  • TABLE 52 SOUTH AFRICA SYNDROMIC MULTIPLEX DIAGNOSTIC MARKET, BY PANELS TYPE, 2018-2027 (USD MILLION)
  • TABLE 53 SOUTH AFRICA SYNDROMIC MULTIPLEX DIAGNOSTIC MARKET, BY END USER, 2018-2027 (USD MILLION)
  • TABLE 54 REST OF MIDDLE EAST AND AFRICA SYNDROMIC MULTIPLEX DIAGNOSTIC MARKET, BY PRODUCTS AND SERVICES, 2018-2027 (USD MILLION)

LIST OF FIGURES

  • FIGURE 1 MIDDLE EAST & AFRICA SYNDROMIC MULTIPLEX DIAGNOSTIC MARKET: SEGMENTATION
  • FIGURE 2 MIDDLE EAST & AFRICA SYNDROMIC MULTIPLEX DIAGNOSTIC MARKET: DATA TRIANGULATION
  • FIGURE 3 MIDDLE EAST & AFRICA SYNDROMIC MULTIPLEX DIAGNOSTIC MARKET: DROC ANALYSIS
  • FIGURE 4 MIDDLE EAST & AFRICA SYNDROMIC MULTIPLEX DIAGNOSTIC MARKET : MIDDLE EAST & AFRICA VS REGIONAL MARKET ANALYSIS
  • FIGURE 5 MIDDLE EAST & AFRICA SYNDROMIC MULTIPLEX DIAGNOSTIC MARKET : COMPANY RESEARCH ANALYSIS
  • FIGURE 6 MIDDLE EAST & AFRICA SYNDROMIC MULTIPLEX DIAGNOSTIC MARKET: INTERVIEW DEMOGRAPHICS
  • FIGURE 7 MIDDLE EAST & AFRICA SYNDROMIC MULTIPLEX DIAGNOSTIC MARKET: DBMR MARKET POSITION GRID
  • FIGURE 8 MIDDLE EAST & AFRICA SYNDROMIC MULTIPLEX DIAGNOSTIC MARKET: VENDOR SHARE ANALYSIS
  • FIGURE 9 MIDDLE EAST & AFRICA SYNDROMIC MULTIPLEX DIAGNOSTIC MARKET: SEGMENTATION
  • FIGURE 10 GROWING PREVALENCE OF INFECTION DISEASES AND GROWING ADOPTION OF MOLECULAR DIAGNOSTICS ARE EXPECTED TO DRIVE THE MIDDLE EAST & AFRICA SYNDROMIC MULTIPLEX DIAGNOSTIC MARKET IN THE FORECAST PERIOD OF 2020 TO 2027
  • FIGURE 11 REAGENTS & CONSUMABLES SEGMENT IS EXPECTED TO ACCOUNT FOR THE LARGEST SHARE OF THE MIDDLE EAST & AFRICA SYNDROMIC MULTIPLEX DIAGNOSTIC MARKET IN 2020 & 2027
  • FIGURE 12 DRIVERS, RESTRAINTS, OPPORTUNITIES AND CHALLENGES OF MIDDLE EAST & AFRICA SYNDROMIC MULTIPLEX DIAGNOSTIC MARKET
  • FIGURE 13 PREVALENCE OF CHRONIC DISEASES
  • FIGURE 14 PERCENTAGE OF DEATHS WORLDWIDE
  • FIGURE 15 TOTAL CASES OF CORONAVIRUS IN NORTH AMERICA
  • FIGURE 16 TOTAL CASES OF CORONAVIRUS IN EUROPE
  • FIGURE 17 TOTAL CASES OF CORONAVIRUS IN ASIA-PACIFIC
  • FIGURE 18 TOTAL CASES OF CORONAVIRUS IN SOUTH AMERICA
  • FIGURE 19 TOTAL CASES OF CORONAVIRUS IN MIDDLE EAST AND AFRICA
  • FIGURE 20 HEALTH SPENDING BY MAJOR SOURCES OF FUNDS
  • FIGURE 21 MIDDLE EAST & AFRICA SYNDROMIC MULTIPLEX DIAGNOSTIC MARKET: BY PRODUCTS AND SERVICES, 2019
  • FIGURE 22 MIDDLE EAST & AFRICA SYNDROMIC MULTIPLEX DIAGNOSTIC MARKET: BY PRODUCTS AND SERVICES, 2019-2027 (USD MILLION)
  • FIGURE 23 MIDDLE EAST & AFRICA SYNDROMIC MULTIPLEX DIAGNOSTIC MARKET: BY PRODUCTS AND SERVICES, CAGR (2020-2027)
  • FIGURE 24 MIDDLE EAST & AFRICA SYNDROMIC MULTIPLEX DIAGNOSTIC MARKET: BY PRODUCTS AND SERVICES, LIFELINE CURVE
  • FIGURE 25 MIDDLE EAST & AFRICA SYNDROMIC MULTIPLEX DIAGNOSTIC MARKET: BY INFECTION TYPE, 2019
  • FIGURE 26 MIDDLE EAST & AFRICA SYNDROMIC MULTIPLEX DIAGNOSTIC MARKET: BY INFECTION TYPE, 2019-2027 (USD MILLION)
  • FIGURE 27 MIDDLE EAST & AFRICA SYNDROMIC MULTIPLEX DIAGNOSTIC MARKET: BY INFECTION TYPE, CAGR (2020-2027)
  • FIGURE 28 MIDDLE EAST & AFRICA SYNDROMIC MULTIPLEX DIAGNOSTIC MARKET: BY INFECTION TYPE, LIFELINE CURVE
  • FIGURE 29 MIDDLE EAST & AFRICA SYNDROMIC MULTIPLEX DIAGNOSTIC MARKET: BY DISEASE, 2019
  • FIGURE 30 MIDDLE EAST & AFRICA SYNDROMIC MULTIPLEX DIAGNOSTIC MARKET: BY DISEASE, 2019-2027 (USD MILLION)
  • FIGURE 31 MIDDLE EAST & AFRICA SYNDROMIC MULTIPLEX DIAGNOSTIC MARKET: BY DISEASE, CAGR (2020-2027)
  • FIGURE 32 MIDDLE EAST & AFRICA SYNDROMIC MULTIPLEX DIAGNOSTIC MARKET: BY DISEASE, LIFELINE CURVE
  • FIGURE 33 MIDDLE EAST & AFRICA SYNDROMIC MULTIPLEX DIAGNOSTIC MARKET: BY PANELS TYPE, 2019
  • FIGURE 34 MIDDLE EAST & AFRICA SYNDROMIC MULTIPLEX DIAGNOSTIC MARKET: BY PANELS TYPE, 2019-2027 (USD MILLION)
  • FIGURE 35 MIDDLE EAST & AFRICA SYNDROMIC MULTIPLEX DIAGNOSTIC MARKET: BY PANELS TYPE, CAGR (2020-2027)
  • FIGURE 36 MIDDLE EAST & AFRICA SYNDROMIC MULTIPLEX DIAGNOSTIC MARKET: BY PANELS TYPE, LIFELINE CURVE
  • FIGURE 37 MIDDLE EAST & AFRICA SYNDROMIC MULTIPLEX DIAGNOSTIC MARKET: BY END USER, 2019
  • FIGURE 38 MIDDLE EAST & AFRICA SYNDROMIC MULTIPLEX DIAGNOSTIC MARKET: BY END USER, 2019-2027 (USD MILLION)
  • FIGURE 39 MIDDLE EAST & AFRICA SYNDROMIC MULTIPLEX DIAGNOSTIC MARKET: BY END USER, CAGR (2020-2027)
  • FIGURE 40 MIDDLE EAST & AFRICA SYNDROMIC MULTIPLEX DIAGNOSTIC MARKET: BY END USER, LIFELINE CURVE
  • FIGURE 41 MIDDLE EAST AND AFRICA SYNDROMIC MULTIPLEX DIAGNOSTIC MARKET: SNAPSHOT (2019)
  • FIGURE 42 MIDDLE EAST AND AFRICA SYNDROMIC MULTIPLEX DIAGNOSTIC MARKET: BY COUNTRY (2019)
  • FIGURE 43 MIDDLE EAST AND AFRICA SYNDROMIC MULTIPLEX DIAGNOSTIC MARKET: BY COUNTRY (2020 & 2027)
  • FIGURE 44 MIDDLE EAST AND AFRICA SYNDROMIC MULTIPLEX DIAGNOSTIC MARKET: BY COUNTRY (2020 & 2027)
  • FIGURE 45 MIDDLE EAST AND AFRICA SYNDROMIC MULTIPLEX DIAGNOSTIC MARKET: BY PRODUCTS AND SERVICES (2018-2027)
  • FIGURE 46 MIDDLE EAST & AFRICA SYNDROMIC MULTIPLEX DIAGNOSTIC MARKET: COMPANY SHARE 2019 (%)
Back to Top